1. Home
  2. MIRM vs SWX Comparison

MIRM vs SWX Comparison

Compare MIRM & SWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$89.49

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

HOLD

Current Price

$88.94

Market Cap

6.4B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
SWX
Founded
2018
1931
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.4B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
MIRM
SWX
Price
$89.49
$88.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
$112.00
$87.40
AVG Volume (30 Days)
601.2K
848.0K
Earning Date
05-18-2026
05-25-2026
Dividend Yield
N/A
2.79%
EPS Growth
74.59
120.29
EPS
N/A
6.08
Revenue
$19,138,000.00
$5,433,972,000.00
Revenue This Year
$24.61
N/A
Revenue Next Year
$21.75
N/A
P/E Ratio
N/A
$14.60
Revenue Growth
N/A
9.56
52 Week Low
$36.88
$64.69
52 Week High
$109.28
$89.45

Technical Indicators

Market Signals
Indicator
MIRM
SWX
Relative Strength Index (RSI) 38.78 66.95
Support Level $72.17 $77.28
Resistance Level $107.51 N/A
Average True Range (ATR) 3.75 1.97
MACD -2.53 0.09
Stochastic Oscillator 12.45 94.34

Price Performance

Historical Comparison
MIRM
SWX

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.

Share on Social Networks: